The impact of integrative medicine on quality of life in patients with diabetes mellitus and cancer
Patients with cancer and DM showed a less significant response to ICM treatments when compared to non-DM patients, emphasizing the need for identifying this sub-population of patients while creating specialized ICM programs tailored to their needs. Future research should focus on exploring the impact of ICM programs on patients with both DM and cancer. Trial registration ClinicalTrials.gov NCT01860365, 2013-05-21.
Authors
- Nili Stein
- Noah Samuels (ORCID: https://orcid.org/0000-0002-1122-9607)
- Orit Gressel (ORCID: https://orcid.org/0000-0002-0184-0453)
- Benjamin Gläser (ORCID: https://orcid.org/0000-0003-4711-5000)
- Eran Ben-Arye
- Sameer Kassem (ORCID: https://orcid.org/0000-0003-3588-0338)
Institutions
- Technion – Israel Institute of Technology (IL)
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- Shaare Zedek Medical Center (IL)
- Carmel Medical Center (IL)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1007/s00520-026-10511-6
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00